Future Member of the S&P 500? These Giants Are Next in Line!1.$AppLovin Corporation(APP)$Core Business & Latest Developments: AppLovin is a leading technology company that provides a suite of software-based solutions for advertisers to enhance their marketing and monetization efforts globally. The company operates through two segments: Advertising and Apps. It offers solutions such as AppDiscovery, MAX, Adjust, and Wurl. Recently, AppLovin announced the sale of its first-party mobile games business to Tripledot Studios, a strategic move aimed at streamlining its operations and focusing on its core advertising business。Financial Highlights: AppLovin reported robust first-quarter results, with a revenue growth of 40.30% and an EPS of 5.51。The

$Datadog(DDOG)$ Datadog Inc. (NASDAQ: DDOG) is set to join the prestigious S&P 500 index, marking a major milestone in the cloud monitoring and analytics company’s journey from fast-growing upstart to established technology leader. The announcement of its inclusion sparked immediate interest from institutional investors and retail traders alike, sending shares up nearly 8% in after-hours trading. For investors, an S&P 500 inclusion can bring both opportunities and risks — boosting visibility and liquidity but also raising expectations and valuation scrutiny. So what does this development mean for Datadog’s stock, and is now the right time to buy, hold, or take profits? In this deep dive, we examine the implications of Datadog’s inclusion i

In a market flooded with overvalued growth stocks and overstated biotech promises, Basel Medical Group Ltd (BMGL) has emerged as a rare hybrid: real revenue, real expansion, and real disruption. The recent 70% single-day surge was not a pump-and-dump. It was the ignition of a story too wild—and too real—to ignore. BMGL runs specialty clinics in Singapore, offering orthopedic and neurosurgical services at Gleneagles Medical Centre. With over $1.5 million in net income in FY2024 and a lean, high-margin model, it already stands out in the microcap world. But that’s just the surface. Where things get interesting is BMGL’s aggressive roadmap: strategic acquisitions in imaging and outpatient care, and most controversially, a $1B Bitcoin-backed financing proposal. The company plans to raise capit

$Intel(INTC)$ Intel Corporation (NASDAQ: INTC) has once again shaken up its semiconductor roadmap, signaling further adjustments in its quest to regain technology leadership and capture a share of the AI-driven server boom. The stock has been battered this year amid execution missteps, fierce competition from NVIDIA (NVDA) and AMD (AMD), and skepticism over its turnaround plan. But does the latest strategic shift represent a buying opportunity for long-term investors, or is it yet another warning sign of a company struggling to find its footing in an industry defined by relentless innovation? In this article, we dissect Intel’s most recent moves — including potential abandonment of its 18A node, possible concessions to win back Apple (AAPL) and Nv